Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
CVS Health Ventures
United States
- Woonsocket, Rhode Island
- 16/11/2022
- Series E
- $90,000,000
CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler.
We invest in and partner with companies with the potential for technology-enabled innovation and disruption in digital health care. Our goal is to enable promising entrepreneurs to scale more quickly and effectively through access to our unmatched enterprise capabilities and consumer touchpoints, while offering expertise and insights from CVS Health's unique perspective.
- Industry Venture Capital and Private Equity Principals
- Website https://www.cvshealth.com/about-cvs-health/ventures
- LinkedIn https://www.linkedin.com/showcase/cvs-health-ventures/
Related People
Karen S. LynchFounder
United States -
Woonsocket, Rhode Island
As President and Chief Executive Officer of CVS Health, I’m focused on supporting individuals during every meaningful moment of health throughout their lifetime.
With a team of more than 300,000 colleagues, I lead CVS Health’s strategy to transform health care to be simpler, more convenient and more personalized. We are working to create a health system that will help you wherever you are – in the community, in the home, and digitally – with solutions that connect and simplify everyday interactions.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)